{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:40:19Z","timestamp":1773294019444,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"British Columbia Mental Health and Substance Use Services"},{"name":"University of British Columbia Faculty of Graduate and Postdoctoral Studies"},{"name":"British Columbia Children's Hospital"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalnutritionespen.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.clnesp.2017.09.013","type":"journal-article","created":{"date-parts":[[2017,10,17]],"date-time":"2017-10-17T08:19:12Z","timestamp":1508228352000},"page":"205-211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Diet and cardiometabolic side effects in children treated with second-generation antipsychotics"],"prefix":"10.1016","volume":"23","author":[{"given":"Mikaela K.","family":"Barker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carly M.","family":"Sable","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorrie","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy J.","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1379-7472","authenticated-orcid":false,"given":"Constadina","family":"Panagiotopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela M.","family":"Devlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2017.09.013_bib1","series-title":"Reaching for the top: a report by the advisor on health children and youth","author":"Leitch","year":"2007"},{"key":"10.1016\/j.clnesp.2017.09.013_bib2","series-title":"Statistics office of national statistics","article-title":"Mental health of children and young people in Great Britain, 2004","author":"Green","year":"2005"},{"key":"10.1016\/j.clnesp.2017.09.013_bib3","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jaac.2010.05.017","article-title":"Lifetime prevalence of mental disorders in U.S. Adolescents: results from the national comorbidity Survey replication\u2013adolescent supplement (NCS-A)","volume":"49","author":"Merikangas","year":"2010","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clnesp.2017.09.013_bib4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/070674371305800608","article-title":"A\u00a0population-based study of antipsychotic prescription trends in children and adolescents in British Columbia from 1996 to 2011","volume":"58","author":"Ronsley","year":"2013","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.clnesp.2017.09.013_bib5","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrendo.2011.156","article-title":"Metabolic and cardiovascular adverse effects associated with antipsychotic drugs","volume":"8","author":"De Hert","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.clnesp.2017.09.013_bib6","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1038\/tp.2011.68","article-title":"Cardiometabolic risk and the MTHFR C677T variant in children treated with second-generation antipsychotics","volume":"2","author":"Devlin","year":"2012","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.clnesp.2017.09.013_bib7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/070674371205700107","article-title":"Waist circumference is a sensitive screening tool for assessment of metabolic syndrome risk in children treated with second-generation antipsychotics","volume":"57","author":"Panagiotopoulos","year":"2012","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.clnesp.2017.09.013_bib8","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1177\/070674370905401104","article-title":"Increased prevalence of obesity and glucose intolerance in youth treated with second-generation antipsychotic medications","volume":"54","author":"Panagiotopoulos","year":"2009","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.clnesp.2017.09.013_bib9","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.2009.1549","article-title":"Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents","volume":"302","author":"Correll","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.clnesp.2017.09.013_bib10","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jaac.2016.02.016","article-title":"Weight gain and metabolic consequences of risperidone in young children with autism spectrum disorder","volume":"55","author":"Scahill","year":"2016","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clnesp.2017.09.013_bib11","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jaac.2014.08.009","article-title":"Second-generation antipsychotic use in children and adolescents: a six-month prospective cohort study in drug-na\u00efve patients","volume":"53","author":"Arango","year":"2014","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clnesp.2017.09.013_bib12","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/01.jcp.0000130558.86125.5b","article-title":"Comparison of risperidone-induced weight gain across the age span","volume":"24","author":"Safer","year":"2004","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.clnesp.2017.09.013_bib13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/cap.2010.0020","article-title":"Comparison of long-term (at least 24 weeks) weight gain and metabolic changes between adolescents and adults treated with olanzapine","volume":"22","author":"Kryzhanovskaya","year":"2012","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.clnesp.2017.09.013_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/jamapsychiatry.2015.2923","article-title":"Type 2 diabetes mellitus in youth exposed to antipsychotics: a systematic review and meta-analysis","volume":"73","author":"Galling","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.clnesp.2017.09.013_bib15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neuroscience.2015.05.067","article-title":"Serotonin, a possible intermediate between disturbed circadian rhythms and metabolic disease","volume":"301","author":"Versteeg","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.clnesp.2017.09.013_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.physbeh.2016.04.020","article-title":"Fuel not fun: reinterpreting attenuated brain responses to reward in obesity","volume":"162","author":"Kroemer","year":"2016","journal-title":"Physiol Behav"},{"key":"10.1016\/j.clnesp.2017.09.013_bib17","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/oby.2008.277","article-title":"Adiposity and eating behaviors in patients under second generation antipsychotics","volume":"16","author":"Blouin","year":"2008","journal-title":"Obesity"},{"key":"10.1016\/j.clnesp.2017.09.013_bib18","first-page":"33","article-title":"Dietary saturated fat intake and glucose metabolism impairments in nondiabetic, nonobese patients with schizophrenia on clozapine or risperidone","volume":"22","author":"Evins","year":"2010","journal-title":"Ann Clin Psychiatry"},{"key":"10.1016\/j.clnesp.2017.09.013_bib19","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1038\/oby.2010.6","article-title":"Increased food intake and energy expenditure following administration of olanzapine to healthy men","volume":"18","author":"Fountaine","year":"2010","journal-title":"Obesity"},{"key":"10.1016\/j.clnesp.2017.09.013_bib20","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1176\/appi.ajp.159.6.1055","article-title":"Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine","volume":"159","author":"Gothelf","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clnesp.2017.09.013_bib21","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/pr.2015.160","article-title":"LMS tables for waist-circumference and waist-height ratio z-scores in children aged 5-19y in NHANES III: association with cardio-metabolic risks","volume":"78","author":"Sharma","year":"2015","journal-title":"Pediatr Res"},{"key":"10.1016\/j.clnesp.2017.09.013_bib22","series-title":"CDC growth charts: United States","first-page":"1","author":"Kuczmanski","year":"2000"},{"key":"10.1016\/j.clnesp.2017.09.013_bib23","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1542\/peds.2007-2329C","article-title":"Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report","volume":"120","author":"Barlow","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.clnesp.2017.09.013_bib24","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(07)60958-1","article-title":"The metabolic syndrome in children and adolescents","volume":"369","author":"Zimmet","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.clnesp.2017.09.013_bib25","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.clnesp.2017.09.013_bib26","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1542\/peds.114.2.S2.555","article-title":"The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents","volume":"114","author":"National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.clnesp.2017.09.013_bib27","series-title":"Dietary reference intakes for energy, carbohydrates, fiber, fat, fatty acids, cholesterol, protein, and amino acids","author":"Food and Nutrition Board Institute of Medicine of the National Academies","year":"2005"},{"key":"10.1016\/j.clnesp.2017.09.013_bib28","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1016\/j.jacc.2013.11.003","article-title":"2013 AHA\/ACC guideline on lifestyle management to reduce cardiovascular risk. A report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines","volume":"63","author":"Eckel","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.clnesp.2017.09.013_bib29","series-title":"Guidelines: sugars intake for adults and children","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.clnesp.2017.09.013_bib30","doi-asserted-by":"crossref","first-page":"e1721","DOI":"10.1542\/peds.2006-0682","article-title":"Estimating the energy gap among US children: a counterfactual approach","volume":"118","author":"Wang","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.clnesp.2017.09.013_bib31","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/sj.ijo.0803533","article-title":"No effect of dietary fat on short-term weight gain in mice treated with atypical antipsychotic drugs","volume":"31","author":"Cope","year":"2007","journal-title":"Int J Obes"},{"key":"10.1016\/j.clnesp.2017.09.013_bib32","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.clnu.2011.03.007","article-title":"Influence of resting energy expenditure on weight gain in adolescents taking second-generation antipsychotics","volume":"30","author":"Cuerda","year":"2011","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnesp.2017.09.013_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-016-3038-5","article-title":"Assessing the nutritional quality of diets of Canadian children and adolescents using the 2014 health Canada surveillance tool tier system","volume":"16","author":"Jessri","year":"2016","journal-title":"BMC Public Health"},{"key":"10.1016\/j.clnesp.2017.09.013_bib34","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jadohealth.2014.12.001","article-title":"Usual intake of added sugars and lipid profiles among the U.S. Adolescents: national health and nutrition examination Survey, 2005\u20132010","volume":"56","author":"Zhang","year":"2015","journal-title":"J\u00a0Adolesc Health"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457717300700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457717300700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T23:20:33Z","timestamp":1559344833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457717300700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":34,"alternative-id":["S2405457717300700"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2017.09.013","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diet and cardiometabolic side effects in children treated with second-generation antipsychotics","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2017.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}